December 27, 2024 03:11 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
I have lost a mentor and guide: Rahul Gandhi writes on Manmohan Singh's demise | Manmohan Singh left strong imprint on our economic policy over years: PM Modi | A rare leader who spoke softly but achieved monumental strides: Gautam Adani mourns Manmohan Singh's death | Instagram influencer and freelance RJ Simran Singh dies by suicide in Gurugram | Anna University sexual assault case: Accused is a DMK worker, claims BJP's Annamalai | Celebrities too responsible for crowd control: Telangana CM Revanth Reddy to Telugu filmdom amid Pushpa 2 stampede row | Boat capsizes off Calangute Beach in Goa; 1 killed, 20 rescued | Canada announces change to immigration system, likely to impact Indians seeking permanent residence | Azerbaijan Airlines tragedy: 32 passengers rescued, flight attempted several emergency landing before crashing | Man sets himself on fire near Parliament building; locals, police rush him to hospital

Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India

Mar 28, 2024, at 05:26 am

New Delhi: Hyderabad-based pharmaceutical major Dr. Reddy’s Laboratories Limited (DRL) on Wednesday announced an exclusive partnership with Sanofi Healthcare India Private Limited to promote and distribute Sanofi’s vaccine brands across the country.

Sanofi partners with Cipla to distribute and promote its Central Nervous System product range in India

Mar 27, 2024, at 06:16 am

Mumbai: Pharma companies Sanofi India and Cipla Limited on Tuesday announced an exclusive partnership for the distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India.

Sanofi appoints Nikhilesh Kalra to lead consumer healthcare business for India, South Asia

Apr 13, 2017, at 03:45 am

Kolkata/Mumbai, Apr 12 (IBNS): Sanofi announced the appointment of Nikhilesh Kalra as the General Manager of its Consumer Healthcare (CHC) business in India and South Asia.

Sanofi, Regeneron announce positive Dupilumab Topline results from two phase 3 trials

Apr 02, 2016, at 04:39 am

Kolkata/Paris, Apr 1 (IBNS) Sanofi and Regeneron Pharmaceuticals, Inc. announced that two placebo-controlled Phase 3 studies evaluating investigation dupilumab in adult patients with inadequately controlled moderate-to-severe atopic dermatitis (AD) met their primary endpoints.

Sanofi appoints Suresh Kumar to Executive Committee

May 27, 2015, at 11:43 pm

Paris, May 27 (IBNS): Sanofi on Wednesday announced the appointment of Suresh Kumar as a new member of the Executive Committee, effective June 1, 2015.